WARSAW, Ind., Jun 17, 2002 -- Zimmer
Holdings, Inc. (NYSE: ZMH) today announced that it expects its second quarter
2002 performance to exceed First Call consensus expectations. The company said
it projects that revenue for the quarter will exceed consensus estimates of $327
million by at least $10 million and that earnings per share for the quarter will
exceed consensus estimates of $0.29 per share by at least $.02 per share.
Zimmer Holdings will discuss its actual results for the second quarter and the
six months ending June 30, 2002, during an investor conference call to be held
on Thursday, July 25, 2002, at 8am EDT. A live audio webcast of Zimmer's
conference call will be accessible through the Zimmer website at
http://www.zimmer.com (Investor Relations section). The webcast will be archived
for future replay.
Individuals who wish to dial into the conference call may do so at 800-406-1106.
International callers should dial (706) 634-7075. A digital recording will be
available two hours after the completion of the conference from July 25, 2002 to
August 8, 2002. To access the recording, US/Canada callers should dial
800-642-1687, or for International callers, dial 706-645-9291, and enter the
Conference ID, 4550669.
Zimmer, based in Warsaw, Indiana, is a global leader in the design, development,
manufacture and marketing of reconstructive orthopaedic implants and fracture
management products. Orthopaedic reconstruction implants restore joint function
lost due to disease or trauma in joints such as knees, hips, shoulders and
elbows. Fracture management products are devices used primarily to reattach or
stabilize damaged bone and tissue to support the body's natural healing process.
Zimmer also manufactures and markets other products related to orthopaedic and
general surgery. For the year 2001, Zimmer recorded worldwide revenues of
approximately $1.2 billion. Zimmer was founded in 1927 and has more than 3,400
employees worldwide.
Visit Zimmer on the worldwide web at http://www.zimmer.com
This press release contains forward-looking statements based on current
expectations, estimates, forecasts and projections about the orthopaedics
industry, management's beliefs and assumptions made by management.
Forward-looking statements may be identified by the use of forward-looking terms
such as "may," "will," "expects," "believes," "anticipates," "plans,"
"estimates," "projects," "targets," "forecasts," and "seeks" or the negative of
such terms or other variations on such terms or comparable terminology. These
statements are not guarantees of future performance and involve risks,
uncertainties and assumptions that could cause actual outcomes and results to
differ materially. These risks and uncertainties include, but are not limited
to, price and product competition, rapid technological development, demographic
changes, dependence on new product development, the mix of our products and
services, customer demand for our products and services, our ability to
successfully integrate acquired companies, control of costs and expenses, our
ability to form and implement alliances, international growth, U.S. and foreign
government regulation, reimbursement levels from third-party payors, general
industry and market conditions and growth rates and general domestic and
international economic conditions including interest rate and currency exchange
rate fluctuations. For a further list and description of such risks and
uncertainties, see the reports filed by Zimmer with the Securities and Exchange
Commission. Zimmer disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.
SOURCE Zimmer Holdings, Inc.
CONTACT: Media - Brad Bishop, Public Affairs, +1-574-372-4291,
[email protected], or Investors - Sam Leno, Chief Financial Officer,
+1-574-372-4790, [email protected], both for Zimmer Holdings, Inc.
Close window | Back to top